SPAC News

Welsbach Critical Materials
SPAC News

EM&T Before Nasdaq Launch: SPAC Merger with Geopolitical Impact

The declaration of effectiveness for the Form S-4 registration statement by the U.S. Securities and Exchange Commission (SEC) paves the way for the planned merger between Welsbach Technology Metals Acquisition Corp. (WTMA), a SPAC, and Evolution Metals LLC (EM). The resulting combined company, Evolution Metals & Technologies Corp. (EM&T), expected to trade on Nasdaq under the symbol EMAT, positions itself as a fully integrated player in the critical minerals and materials (CMM) supply chain, aiming for independence from China.

EM&T Before Nasdaq Launch: SPAC Merger with Geopolitical Impact Read more »

Biotechnology
SPAC News

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement

Zurich, Switzerland, and Brooklyn, New York, USA – VERAXA Biotech AG and Voyager Acquisition Corp. (NASDAQ: VACH) have announced a definitive business combination agreement. The proposed combination would result in a publicly traded, clinical-stage biopharmaceutical company, VERAXA Biotech AG, focused on next-generation cancer therapies, and is expected to list on NASDAQ under the ticker symbol “VERX.”

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement Read more »

Health
SPAC News

Aimfinity Investment Corp. I Announces Approval by Shareholders of its Business Combination with Docter Inc.

Wilmington, DE – Aimfinity Investment Corp. I (Nasdaq: AIMA, AIMAU, AIMAW) announced that its business combination with Docter Inc., a Taiwanese health technology company, was approved at an extraordinary general meeting of shareholders on March 27, 2025.

Aimfinity Investment Corp. I Announces Approval by Shareholders of its Business Combination with Docter Inc. Read more »

Scroll to Top